BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 37360529)

  • 1. Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection.
    Zhao M; Zhang M; Yang Z; Zhou Z; Huang J; Zhao B
    Front Cell Infect Microbiol; 2023; 13():1217383. PubMed ID: 37360529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRL4B E3 ligase recruited by PRPF19 inhibits SARS-CoV-2 infection by targeting ORF6 for ubiquitin-dependent degradation.
    Zhang L; Hao P; Chen X; Lv S; Gao W; Li C; Li Z; Zhang W
    mBio; 2024 Feb; 15(2):e0307123. PubMed ID: 38265236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E3 Ubiquitin Ligase RNF5 Facilitates SARS-CoV-2 Membrane Protein-Mediated Virion Release.
    Yuan Z; Hu B; Xiao H; Tan X; Li Y; Tang K; Zhang Y; Cai K; Ding B
    mBio; 2021 Feb; 13(1):e0316821. PubMed ID: 35100873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
    Yu M; Li J; Gao W; Li Z; Zhang W
    J Virol; 2024 Jun; 98(6):e0162423. PubMed ID: 38709105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome substrate receptors and their therapeutic potential.
    Osei-Amponsa V; Walters KJ
    Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deubiquitinase USP39 promotes SARS-CoV-2 replication by deubiquitinating and stabilizing the envelope protein.
    Chen X; Tian L; Zhang L; Gao W; Yu M; Li Z; Zhang W
    Antiviral Res; 2024 Jan; 221():105790. PubMed ID: 38158131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into a functional model of key deubiquitinases UBP12/13 in plants.
    Zhang S; Hu N; Yu F
    New Phytol; 2024 Apr; 242(2):424-430. PubMed ID: 38406992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Deubiquitinase USP29 Promotes SARS-CoV-2 Virulence by Preventing Proteasome Degradation of ORF9b.
    Gao W; Wang L; Ju X; Zhao S; Li Z; Su M; Xu J; Wang P; Ding Q; Lv G; Zhang W
    mBio; 2022 Jun; 13(3):e0130022. PubMed ID: 35638730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidden targets of ubiquitin proteasome system: To prevent diabetic nephropathy.
    Goru SK; Kadakol A; Gaikwad AB
    Pharmacol Res; 2017 Jun; 120():170-179. PubMed ID: 28363724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural modeling of protein ensembles between E3 RING ligases and SARS-CoV-2: The role of zinc binding domains.
    Chasapis CT; Perlepes SP; Bjørklund G; Peana M
    J Trace Elem Med Biol; 2023 Jan; 75():127089. PubMed ID: 36209710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of T helper cell differentiation by E3 ubiquitin ligases and deubiquitinating enzymes.
    Gao SF; Zhong B; Lin D
    Int Immunopharmacol; 2017 Jan; 42():150-156. PubMed ID: 27914308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
    FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
    Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
    J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recycling and Reshaping-E3 Ligases and DUBs in the Initiation of T Cell Receptor-Mediated Signaling and Response.
    Cammann C; Israel N; Slevogt H; Seifert U
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2.
    Xu G; Wu Y; Xiao T; Qi F; Fan L; Zhang S; Zhou J; He Y; Gao X; Zeng H; Li Y; Zhang Z
    Signal Transduct Target Ther; 2022 Sep; 7(1):312. PubMed ID: 36071039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8.
    Fan L; Zhou Y; Wei X; Feng W; Guo H; Li Y; Gao X; Zhou J; Wen Y; Wu Y; Shen X; Liu L; Xu G; Zhang Z
    mBio; 2024 Feb; 15(2):e0232023. PubMed ID: 38275298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein partners of deubiquitinating enzymes.
    Ventii KH; Wilkinson KD
    Biochem J; 2008 Sep; 414(2):161-75. PubMed ID: 18687060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of Ubiquitination in Differentiation and Dedifferentiation of Pancreatic β-cells: Putative Target for Diabetes.
    Francis M; Bhaskar S; Vishnuvajhala S; Prasanna J; Kumar A
    Curr Protein Pept Sci; 2022; 23(9):602-618. PubMed ID: 35466872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers.
    Park HB; Baek KH
    Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188736. PubMed ID: 35589008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the ubiquitin proteasome system in hematologic malignancies.
    Sahasrabuddhe AA; Elenitoba-Johnson KS
    Immunol Rev; 2015 Jan; 263(1):224-39. PubMed ID: 25510280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.